Sen-Jam Pharmaceutical Patents – Insights & Stats (Updated 2023)

Sen-Jam Pharmaceutical has a total of 40 patents globally, out of which 10 have been granted. Of these 40 patents, more than 70% patents are active. The United States of America is where Sen-Jam Pharmaceutical has filed the maximum number of patents, followed by Europe (EPO) and Australia. Parallelly, The United States of America seems to be the main focused R&D center and also origin country of Sen-Jam Pharmaceutical.

Sen-Jam Pharmaceutical was founded in the year 2014. Sen-Jam Pharmaceutical is a medical company that uses the development pathway to create innovative pharmaceutical solutions for significant unmet needs.

Do read about some of the most popular patents of Sen-Jam Pharmaceutical which have been covered by us in this article and also you can find Sen-Jam Pharmaceutical patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Sen-Jam Pharmaceutical patent portfolio.

How many patents does Sen-Jam Pharmaceutical have?

Sen-Jam Pharmaceutical has a total of 40 patents globally. These patents belong to 9 unique patent families. Out of 40 patents, 28 patents are active.

How Many Patents did Sen-Jam Pharmaceutical File Every Year?

Sen-Jam Pharmaceutical Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantSen-Jam Pharmaceutical Applications FiledSen-Jam Pharmaceutical Patents Granted
202331
202225
202181
202022
201931
201815
20167

How many Sen-Jam Pharmaceutical patents are Alive/Dead?

Worldwide Patents

Sen-Jam Pharmaceutical patent Portfolio

How Many Patents did Sen-Jam Pharmaceutical File in Different Countries?

Sen-Jam Pharmaceutical Worldwide Patent Filing

Countries in which Sen-Jam Pharmaceutical Filed Patents

CountryPatent
United States Of America13
Europe5
Australia3
Canada2
Mexico1
Poland1
New Zealand1
Brazil1
Austria1
Singapore1
Spain1
South Africa1
Israel1
Italy1

Where are Research Centers of Sen-Jam Pharmaceutical Patents Located?

R&D Ceentres of Sen-Jam Pharmaceutical

What Percentage of Sen-Jam Pharmaceutical US Patent Applications were Granted?

Sen-Jam Pharmaceutical (Excluding its subsidiaries) has filed 9 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 6 have been granted leading to a grant rate of 75%.

Below are the key stats of Sen-Jam Pharmaceutical patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Sen-Jam Pharmaceutical?

Law FirmTotal ApplicationsSuccess Rate
Morgan Lewis & Bockius Llp Bo975.0%

List of Sen-Jam Pharmaceutical patents

Sen-Jam Pharmaceutical PatentsTitle
US11464766B2Methods And Compositions To Inhibit Symptoms Associated With Veisalgia
US11129803B2Methods And Compositions To Inhibit Tolerance To Opioids
US10765630B2Methods And Compositions To Treat Enteropathic Arthritis
US10675261B2Methods And Compositions To Inhibit Dependence On Opioids
US10420756B2Methods And Compositions To Inhibit Symptoms Associated With Veisalgia
US20230064685A1Methods And Compositions To Inhibit Symptoms Associated With Veisalgia
US20220265585A1Methods And Compositions To Inhibit Symptoms Associated With Opioid Withdrawal
US20220096409A1Methods And Compositions To Inhibit Tolerance To Opioids
US20210212971A1Methods And Compositions To Inhibit Dependence On Opioids
US20200297707A1Methods And Compositions To Inhibit Symptoms Associated With Viral Upper Respiratory Tract Infections
EP3273952B1Combination Of Naproxen And Fexofenadine To Inhibit Symptoms Associated With Veisalgia
EP4192457A1Compositions And Methods For Treating Or Preventing Disease Associated With Beta Coronavirus Infection
EP3973957A1Methods And Compositions To Inhibit Symptoms Associated With Veisalgia
AU2018333954B2Methods And Compositions To Inhibit Dependence On Opioids
AU2021321535A1Compositions And Methods For Treating Or Preventing Disease Associated With Beta Coronavirus Infection
AU2018333952A1Methods And Compositions To Inhibit Symptoms Associated With Opioid Withdrawal
CA3076197A1Methods And Compositions To Inhibit Dependence On Opioids
CA3076193A1Methods And Compositions To Inhibit Symptoms Associated With Opioid Withdrawal
IL300406ACompositions And Methods For Treating Or Preventing Disease Associated With Beta Coronavirus Infection
SG11202300846SACompositions And Methods For Treating Or Preventing Disease Associated With Beta Coronavirus Infection
BR112023002233A2Compositions And Methods For Treating Or Preventing Disease Associated With Beta Coronavirus Infection
PL3273952T3Combination Of Naproxen And Fexofenadine To Inhibit Symptoms Associated With Veisalgia
ES2926494T3Combination Of Naproxen And Fexofenadine To Inhibit Symptoms Associated With Veisalgia
IT202200057570T2Combination Of Naproxene And Phexofenadine To Inhibit Symptoms Associated With Veisalgia
MX2023001570ACompositions And Methods For Treating Or Preventing A Disease Associated With Betacoronavirus Infection
ZA202303234ACompositions And Methods For Treating Or Preventing Disease Associated With Beta Coronavirus Infection
AT1497959TKombination Von Naproxen Und Fexofenadine Zur Hemmung Von Symptomen Im Zusammenhang Mit Veisalgia
NZ797537ACompositions And Methods For Treating Or Preventing Disease Associated With Beta Coronavirus Infection
US20200297673A1Methods And Compositions To Inhibit Dependence On Opioids
US20190083430A1Methods And Compositions To Inhibit Symptoms Associated With Opioid Withdrawal
US20180360811A1Methods And Compositions To Inhibit Symptoms Associated With Viral Upper Respiratory Tract Infections
EP3684360A4Methods And Compositions To Inhibit Dependence On Opioids
EP3684347A4Methods And Compositions To Inhibit Symptoms Associated With Opioid Withdrawal
WO2022032069A1Compositions And Methods For Treating Or Preventing Disease Associated With Beta Coronavirus Infection
WO2019178516A1Methods And Compositions To Treat Enteropathic Arthritis
WO2019055942A4Methods And Compositions To Inhibit Tolerance To Opioids
WO2019055941A1Methods And Compositions To Inhibit Dependence On Opioids
WO2019055939A1Methods And Compositions To Inhibit Symptoms Associated With Opioid Withdrawal
WO2019046201A1Methods And Compositions To Inhibit Adverse Effects Associated With Vaccinations
WO2018232260A1Methods And Compositions To Inhibit Symptoms Associated With Viral Upper Respiratory Tract Infections

What are Sen-Jam Pharmaceutical key innovation segments?

What Technologies are Covered by Sen-Jam Pharmaceutical?

The chart below distributes patents filed by Sen-Jam Pharmaceutical in different countries on the basis of the technology protected in patents. It also represents the markets where Sen-Jam Pharmaceutical thinks it’s important to protect particular technology inventions.

R&D Focus: How has Sen-Jam Pharmaceutical search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Sen-Jam Pharmaceutical?

Related Articles

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.